INO

#3501
Inovio Pharmaceuticals, Inc. - Common Stock
1.3 1 USD
0.00%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
1.31
1.31
Range Annuel
1.03
2.98
Changement quotidien
0.00%
Changement Mensuel
+15.93%
Evolution sur 6 mois
-36.41%
Changement Annuel
-38.21%
Clôture Précédente
1.3 1
Open
1.3 1
Low
1.3 1
High
1.3 1
Volume
36
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 107.78 M
  • Employee 112
  • Founded 1999
  • CEO Jacqueline Shea
  • Website www.inovio.com
  • Headquarter Delaware, United States
  • FIGI BBG000BK6YX5
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.96
ratio cours/chiffre d'affaires
1 248.52

Inovio Pharmaceuticals, Inc. - Common Stock

Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development.

Nouvelles